arrow
S

Susan Buchbinder

nih national institute of allergy and infectious diseases
H指数:98
被引数:4.7万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Alimatravir Oral Once Monthly in Adults With Low Likelihood of HIV Exposure: A Randomized, Double-Blind, Placebo-Controlled Study

阿利马特拉韦口服每月一次用于低HIV暴露风险的成人:一项随机、双盲、安慰剂对照研究

2026-09-220
OAAI
Quantifying how HIV-1 envelope sequence features impact vaccine efficacy in the HVTN 705/HPX2008 randomised trial in southern African women

量化HIV-1包膜序列特征如何影响HVTN 705/HPX2008随机试验中南部非洲女性的疫苗效果

2026-08-010
PRE
Efficacy and safety of a mosaic HIV-1 vaccine regimen in men who have sex with men and transgender individuals (HVTN 706/HPX3002/Mosaico): a global, randomised, double-blind, placebo-controlled, phase 3 trial
2025-11-260
PRE
Corrigendum to ‘Immune correlates analysis of the Imbokodo (HVTN 705/HPX2008) efficacy trial of a mosaic HIV-1 vaccine regimen evaluated in Southern African people assigned female sex at birth: a two-phase case-control study’. EBioMedicine 2024;108: 105320

勘误:‘在南部非洲出生时被指定为女性的人群中评估的镶嵌HIV-1疫苗方案免疫原性试验的免疫相关性分析:一项两阶段病例对照研究’。EBioMedicine 2024;108: 105320

2025-08-230
PREAI
Implementation Barriers and Facilitators in a Pilot Long-Acting HIV Treatment Intervention for Trans Women Living with HIV in San Francisco

在旧金山生活并患有HIV的跨性别女性中,一项试点长效HIV治疗干预措施的实施方案障碍与促进因素

2025-07-040
PRE
Antiretroviral Drugs for Treatment and Prevention of HIV in Adults: 2024 Recommendations of the International Antiviral Society-USA Panel
2025-02-181
PRE
Mosaic HIV-1 vaccine regimen in southern African women (Imbokodo/HVTN 705/HPX2008): a randomised, doubleblind, placebo-controlled, phase 2b trial
2024-11-014
OAAI
Immune correlates analysis of the Imbokodo (HVTN 705/HPX2008) efficacy trial of a mosaic HIV-1 vaccine regimen evaluated in Southern African people female sex at birth: a case-control study
2024-10-010
PRE
Point-of-care urine tenofovir test predicts future HIV preexposure prophylaxis discontinuation among young users

护理点尿液替诺福韦测试预测年轻用户未来的HIV暴露前预防停药

AIDS
IF3.1
2024-06-200
PRE
Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults 2022 Recommendations of the International Antiviral Society-USA Panel
2023-01-03286
PRE
Baseline host determinants of robust human HIV-1 vaccine-induced immune responses: A meta-analysis of 26 vaccine regimens
2022-10-014
OAAI